- List
- By Topic
- On Map
- Search Details

17215530 [PUBMED-IDS]
Need help? See RSS Feeds
Choose a feed type:

17215530 [PUBMED-IDS] (6 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT01762150 | Active, not recruiting | Sorafenib Combined With Chemotherapy for Renal Collecting Duct Carcinoma |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
26 | All | 18 Years to 70 Years (Adult, Senior) | NCT01762150 | BCH-RCC-120601 | June 2011 | December 2016 | June 2017 | January 7, 2013 | May 9, 2017 |
|
||
2 | NCT00619268 | Completed | Combination of Temsirolimus and Bevacizumab in Patient With Metastatic Renal Cell Carcinoma |
|
|
Interventional | Phase 2 |
|
Other |
|
|
160 | All | 18 Years and older (Adult, Senior) | NCT00619268 | TORAVA ET2007-035 |
TORAVA | February 2008 | February 2012 | February 2012 | February 20, 2008 | February 15, 2013 |
|
|
3 | NCT00933777 | Completed | SORAVE - Sorafenib and Everolimus in Solid Tumors |
|
|
Interventional | Phase 1 |
|
Other |
|
|
36 | All | 18 Years and older (Adult, Senior) | NCT00933777 | SORAVE | SORAVE | July 2009 | February 2014 | February 2015 | July 7, 2009 | May 25, 2016 |
|
|
4 | NCT01339975 | Active, not recruiting | Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell Carcinoma |
|
|
Observational |
|
Other |
|
|
310 | All | 18 Years and older (Adult, Senior) | NCT01339975 | CHUBX 2010/45 | ChemoRenCan | June 2011 | May 2014 | May 2019 | April 21, 2011 | April 12, 2018 |
|
||
5 | NCT01202032 | Completed | Multicenter Dose-escalation Study of a Combination of Pazopanib and Bevacizumab in Patients With Metastatic Renal Cell Carcinoma or Others Advanced Solid Tumors |
|
|
Interventional | Phase 1 |
|
Other |
|
|
36 | All | 18 Years and older (Adult, Senior) | NCT01202032 | PARASOL | PARASOL | July 2010 | January 2013 | March 2013 | September 15, 2010 | May 18, 2016 |
|
|
6 | NCT00073307 | Completed Has Results |
Study of BAY43-9006 in Patients With Unresectable and/or Metastatic Renal Cell Cancer |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
903 | All | 18 Years and older (Adult, Senior) | NCT00073307 | 11213 | November 2003 | September 2006 | April 2010 | November 21, 2003 | February 6, 2014 | December 14, 2011 |
|
† Study has passed its completion date and status has not been verified in more than two years.